Impact of switching to injectables cabotegravir and rilpivirine on sleep disturbances in a cohort of people living with HIV

IF 1.7 4区医学 Q3 INFECTIOUS DISEASES

HIV Research & Clinical Practice Pub Date : 2024-05-10 DOI:10.1080/25787489.2024.2351258

Maria Mazzitelli, Elena Agostini, Eleonora Vania, Nicolò Presa, Lolita Sasset, Davide Leoni, Samuele Gardin, Vincenzo Scaglione, Annamaria Cattelan

引用次数: 0

Abstract

Recently, injectable cabotegravir/rilpivirine (ICAB/RPV) became available for HIV treatment. However, there are no real-life data on the impact of switching to ICAB/RPV on sleep disturbances (SD). ...

查看原文本刊更多论文

转用注射用卡博替拉韦和利匹韦林对一组艾滋病毒感染者睡眠障碍的影响

最近，注射用卡博替拉韦/利匹韦林（ICAB/RPV）开始用于艾滋病治疗。然而，目前还没有关于改用 ICAB/RPV 对睡眠障碍（SD）影响的真实数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

HIV Research & Clinical Practice Multiple-

CiteScore

2.90

自引率

6.20%

发文量